Last reviewed · How we verify
A Prospective Randomized Control Trial of the Effect of Sorafenib Combined With Aspirin in Preventing the Recurrence in High-risk Patients With Hepatocellular Carcinoma
The purpose of the study is to observe the effect of sorafenib combined with aspirin in preventing the recurrence in high-risk patients with hepatocellular carcinoma.
Details
| Lead sponsor | Fudan University |
|---|---|
| Phase | NA |
| Status | TERMINATED |
| Enrolment | 52 |
| Start date | 2016-04 |
| Completion | 2019-02-11 |
Conditions
- Hepatocellular Carcinoma
Interventions
- control
- sorafenib
- aspirin
Primary outcomes
- Overall survival — 5 years
Countries
China